MICRORNA BASED METHOD FOR DIAGNOSIS OF COLORECTAL TUMORS AND OF METASTASIS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 3, 2015
app pub date -
Sep 20, 2013
filing date -
Sep 24, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention encompasses the identification and selection of novel miRNAs as biomarkers so as to provide a method for the diagnosis of colorectal cancer. The miRNAs identified are differentially expressed in subjects with colorectal cancer compared to subjects without colorectal cancer. Further, some of the identified miRNAs were found to play a critical role for the progression of colorectal cancer into metastasis and, thus, facilitate a differential diagnosis between tumor and metastasis. Nucleic acids which are capable of specifically detecting the miRNAs identified are also encompassed within the scope of the invention as are sets of said nucleic acids, which arc particularly suited for being used in multiplex RT-PCR or in array techniques. Further encompassed are compositions and kits containing said nucleic acids and nucleic acids for use in diagnosing colorectal cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully